Latest Commercialization News

American Uranium has completed a A$2.64 million placement by issuing 22 million shares at A$0.12 each, aiming to fund drilling and technical studies at its Wyoming uranium projects.

Minbos Resources has secured a US$5.48 million debt facility from Banco de Fomento Angola, complementing a prior US$16 million loan from South Africa’s IDC, ensuring full funding to complete construction of its Cabinda Phosphate Fertilizer Plant.

Botanix Pharmaceuticals has agreed to terms with Piramal to establish an alternate supplier for the active ingredient in Sofdra, aiming to reduce costs by up to 40% and strengthen its supply chain.

88 Energy has bolstered its Alaska North Slope exploration with a substantial prospective resource update, fresh seismic data acquisitions, and a heavily oversubscribed A$5 million equity placement, setting the stage for its Augusta-1 well spud in early 2027.

Audeara has locked in exclusive Australian rights to a customised assistive listening device from ShokzHear, aiming to tackle widespread listening challenges among schoolchildren through government-backed programs.

GoldArc Resources has locked in a binding agreement with Mineral Mining Services to fully fund the development of its Leonora South gold deposits, removing capital barriers and setting a clear path to production.

Ora Banda Mining delivered a record 38,800 ounces of gold in the March quarter, generating $76.3 million in free cash flow and boosting cash reserves to $231.7 million. The company also reported a tenfold increase in its Round Dam Mineral Resource to 1.33 million ounces, underpinning its aggressive growth strategy.

Temas Resources is tapping the Canadian market with a $1.5 million flow-through share placement aimed at advancing its titanium projects in Quebec. The raise supports exploration expenses tied to its proprietary processing technology and resource development.

Marquee Resources (ASX:MQR) has secured a non-exclusive R&D patent licence with Oak Ridge National Laboratory, granting access to NEAREST technology tailored for clay-rich rare earth deposits like Redlings in WA. This partnership could reshape processing efficiency and environmental impact for Marquee’s significant inferred resource.

ReNerve has moved its NervAlign Nerve Guide Matrix into stage 3 of commercial development, a key step toward FDA submission and eventual market entry. This progress supports the company’s ambition to provide surgeons with an alternative to donor nerves for repairing severe peripheral nerve injuries.

Charger Metals has confirmed significant extensions to spodumene mineralisation at its Medcalf project, with drilling pushing lithium-bearing pegmatites to 600-700m depth and along strike. The company anticipates a substantial resource upgrade following assay results due in the coming weeks.

Noxopharm appoints its Chief Scientific Officer Dr Olivier Laczka as CEO, aiming to capitalise on recent clinical successes and expand the Sofra™ technology’s reach in autoimmune and oncology markets.